{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:27:42Z","timestamp":1787185662232,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcjo.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T23:54:25Z","timestamp":1776383665000},"page":"908-917","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for ethambutol-induced optic neuropathy: a systematic review and meta-analysis of comparative studies"],"prefix":"10.1016","volume":"61","author":[{"given":"Arnav","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Tejpal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1667-6764","authenticated-orcid":false,"given":"Aswen","family":"Sriranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benson","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P.","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edsel B.","family":"Ing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9199-6701","authenticated-orcid":false,"given":"Rahul A.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2026.03.004_bib0001","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4103\/0301-4738.77035","article-title":"Toxic optic neuropathy","volume":"59","author":"Sharma","year":"2011","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0002","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/ICU.0000000000000416","article-title":"Ethambutol optic neuropathy","volume":"28","author":"Chamberlain","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0003","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1006\/taap.1999.8846","article-title":"Ethambutol-induced vacuolar changes and neuronal loss in rat retinal cell culture: mediation by endogenous zinc","volume":"162","author":"Yoon","year":"2000","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0004","first-page":"977","article-title":"Ethambutol induces impaired autophagic flux and apoptosis in the rat retina","volume":"8","author":"Huang","year":"2015","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.taap.2008.11.006","article-title":"Ethambutol-induced toxicity is mediated by zinc and lysosomal membrane permeabilization in cultured retinal cells","volume":"235","author":"Chung","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0006","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1080\/02713683.2018.1504086","article-title":"Mitochondrial impairment in antibiotic induced toxic optic neuropathies","volume":"43","author":"Yu","year":"2018","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0007","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1442-9071.2010.02240.x","article-title":"Antituberculosis medication as a possible epigenetic factor of Leber\u2019s hereditary optic neuropathy","volume":"38","author":"Seo","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0008","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s10384-005-0308-7","article-title":"Leber\u2019s hereditary optic neuropathy precipitated by ethambutol","volume":"50","author":"Ikeda","year":"2006","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0009","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00415-003-0960-0","article-title":"Leber\u2019s hereditary optic neuropathy mutations in ethambutol-induced optic neuropathy","volume":"250","author":"Hwang","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0010","doi-asserted-by":"crossref","first-page":"218","DOI":"10.4103\/0301-4738.27091","article-title":"Leber\u2019s hereditary optic neuropathy masquerading as ethambutol-induced optic neuropathy in a young male","volume":"54","author":"Chowdhury","year":"2006","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0011","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s004150050223","article-title":"A case of ethambutol-induced optic neuropathy harbouring the primary mitochondrial LHON mutation at nt 11778","volume":"245","author":"Dotti","year":"1998","journal-title":"J Neurol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0012","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mito.2009.11.004","article-title":"Ethambutol-induced optic neuropathy linked to OPA1 mutation and mitochondrial toxicity","volume":"10","author":"Guillet","year":"2010","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0013","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/WNO.0b013e31818f138f","article-title":"Ethambutol optic neuropathy: how we can prevent 100,000 new cases of blindness each year","volume":"28","author":"Sadun","year":"2008","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0014","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.23766","article-title":"Ethambutol toxicity exacerbating the phenotype of CMT2A2","volume":"48","author":"Fonkem","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0015","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5588\/ijtld.15.0275","article-title":"Incidence of toxic optic neuropathy with low-dose ethambutol","volume":"20","author":"Yang","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0016","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1093\/cid\/ciw376","article-title":"Official American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis","volume":"63","author":"Nahid","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0017","series-title":"Drug-resistant tuberculosis: a survival guide for clinicians","author":"Center","year":"2016"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0018","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41433-023-02643-4","article-title":"Ethambutol and visual assessment in England: current practice and recommendations","volume":"38","author":"MacVinish","year":"2024","journal-title":"Eye"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10792-009-9293-z","article-title":"Risk factors for ethambutol optic toxicity","volume":"30","author":"Talbert Estlin","year":"2010","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.105906","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"88","author":"Page","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0021","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0022","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0023","unstructured":"Schunemann HB, Guyatt G, Oxman A. GRADE handbook. Cochrane. Accessed July 29, 2024. https:\/\/gdt.gradepro.org\/app\/handbook\/handbook.html"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0024","first-page":"1694","article-title":"Correlation between the duration of ethambutol therapy and the toxic optic neuropathy occurrence in patients with multidrug-resistance tuberculosis","volume":"14","author":"Hamdan","year":"2020","journal-title":"Ind J Forens Med Toxicol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0025","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/112067210901900323","article-title":"Early stage ethambutol optic neuropathy: retinal nerve fiber layer and optical coherence tomography","volume":"19","author":"Kim","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0026","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/bjophthalmol-2020-316897","article-title":"Prospective study to evaluate incidence and indicators for early detection of ethambutol toxicity","volume":"105","author":"Mandal","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0027","first-page":"967","article-title":"Ethambutol-induced optical neuropathy: risk of overdosing in obese subjects","volume":"12","author":"Hasenbosch","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0028","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.resinv.2021.06.010","article-title":"Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease","volume":"59","author":"Ando","year":"2021","journal-title":"Respir Investig"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0029","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bjophthalmol-2012-301870","article-title":"Ethambutol-induced optic neuropathy: a nationwide population-based study from Taiwan","volume":"96","author":"Chen","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0030","doi-asserted-by":"crossref","DOI":"10.3389\/fopht.2023.1152215","article-title":"Incidence, risk factors and ophthalmic clinical characteristic of ethambutol-induced optic neuropathy: 7-year experience","volume":"3","author":"Chaitanuwong","year":"2023","journal-title":"Front Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0031","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/bjophthalmol-2018-312063","article-title":"Diagnostic value of ganglion cell-inner plexiform layer for early detection of ethambutol-induced optic neuropathy","volume":"103","author":"Lee","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0032","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jcjo.2018.06.013","article-title":"Ethambutol-induced optic neuropathy in renal disorder: a clinico-electrophysiological study","volume":"54","author":"Kanaujia","year":"2019","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0033","first-page":"1","article-title":"Ocular toxicity with ethambutol therapy: Timely recaution","volume":"32","author":"Koul","year":"2015","journal-title":"Lung India"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0034","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1128\/AAC.00412-10","article-title":"Dosing ethambutol in obese patients","volume":"54","author":"Alffenaar","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0035","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/cpt.1871","article-title":"Pregnane X receptor activator rifampin increases blood pressure and stimulates plasma renin activity","volume":"108","author":"Hassani-Nezhad-Gashti","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0036","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archinte.1988.00380050232033","article-title":"Rifampicin and nephrotoxicity","volume":"148","author":"Van Assendelft","year":"1988","journal-title":"Arch Int Med"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0037","article-title":"Mitochondrial dysfunction contributes to hypertensive target organ damage: lessons from an animal model of human disease","volume":"2016","author":"Rubattu","year":"2016","journal-title":"Oxidat Med Cell Longev"},{"key":"10.1016\/j.jcjo.2026.03.004_bib0038","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S2213-8587(14)70110-X","article-title":"Clinical management of concurrent diabetes and tuberculosis and the implications for patient services","volume":"2","author":"Riza","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.jcjo.2026.03.004_bib0039","doi-asserted-by":"crossref","first-page":"469","DOI":"10.4103\/1673-5374.179061","article-title":"Macular thickness as a predictor of loss of visual sensitivity in ethambutol-induced optic neuropathy","volume":"11","author":"Peng","year":"2016","journal-title":"Neural Regen Res"},{"issue":"1","key":"10.1016\/j.jcjo.2026.03.004_bib0040","doi-asserted-by":"crossref","first-page":"21601","DOI":"10.1038\/s41598-020-77160-5","article-title":"Pupillary light reflex in ethambutol-induced optic neuropathy","volume":"10","author":"Yoo","year":"2020","journal-title":"Sci Rep"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226000852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418226000852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:19:36Z","timestamp":1787185176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418226000852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0008418226000852"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.03.004","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for ethambutol-induced optic neuropathy: a systematic review and meta-analysis of comparative studies","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Canadian Ophthalmological Society.","name":"copyright","label":"Copyright"}]}}